AGIOS PHARMACEUTICALS, INC.
Tremor tracks 1 of its cancer trials.
Company-wide warning signs
These add points to every one of this company's trials.
None right now.
Trials
Key executives leaving
From the last 12 months of the company's SEC reports.
None found.
Insider trades (last 6 months)
“Insiders” are executives, board members, and big shareholders. Many of their sales are pre-planned: scheduled months ahead under a legal plan (called 10b5-1), so they usually say little. Tremor only counts sales that weren't pre-planned.
5 sales (0 not pre-planned) · 0 purchases
- Gheuens SarahChief Medical Officer · Oct 26, 2026Sold 7,866 sharesabout $296 thousand · pre-planned
- Gheuens SarahChief Medical Officer · Oct 22, 2026Sold 500 sharesabout $19 thousand · pre-planned
- Gheuens SarahChief Medical Officer · Oct 21, 2026Sold 1,489 sharesabout $56 thousand · pre-planned
- Gheuens SarahChief Medical Officer · Aug 4, 2026Sold 30,000 sharesabout $914 thousand · pre-planned
- Gheuens SarahChief Medical Officer · Jul 1, 2026Sold 4,007 sharesabout $151 thousand · pre-planned
Recent SEC filings
Public companies must report important news and their finances to the SEC, the US agency that oversees the stock market.
Money left
Coming soon: how many months of cash the company has, from its quarterly reports.